Fred Hutchinson Cancer Center
A leader for the Phase I Developmental Therapeutics clinical trials program at Fred Hutchinson Cancer Center and University of Washington, focusing on innovative cancer therapies and translating research into clinical practice.
Fred Hutchinson Cancer Center is a nonprofit research and treatment organization dedicated to eliminating cancer and related diseases. It combines laboratory research, clinical trials, and patient care to improve prevention and treatment across cancers as well as related conditions such as HIV/AIDS and autoimmune diseases. Fred Hutch provides comprehensive patient services (appointments, MyChart, provider and referral resources) and works closely with physicians and partner institutions to translate discoveries into new therapies. The center is known for rigorous science and integrated clinical programs that move innovations from bench to bedside.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Fred Hutchinson Cancer Center.
Associate or Full Professor WOT (Program Head Phase I Clinical Trials)
University of Washington
Associate Professor or Full Professor, Clinician-Scholar, Gastrointestinal Oncology
fredhutchinsoncancercenter.com
Early Phase/Developmental Therapeutics - Yale Cancer Center
Yale University
Senior Project Manager - Clinical Trials
Precision for Medicine
Director of Clinical Research, Assistant, Associate, or Full Professor, Sarcoma Oncology
University of Washington
Professor WOT, Division of Hematology and Oncology (Leukemia Program Head)
University of Washington